Join us on June 9 at 1:00 PM ET for a KDIGO–@Medlive webinar on tackling complement-mediated glomerular diseases like #C3G.
Register: https://kdigo.co/Medlive-KDIGO-Complement-Webinar-June-9
Dr. Richard Lafayette and Dr. Pietro Canetta will discuss the burden of disease, current treatment limitations, and the…
A sample from the pathology teaching slide set on Minimal Change Disease in Adults, jointly prepared by Arkana Laboratories and @goKDIGO. http://KDIGO.org/guidelines/gd/
#KDIGO #pathology #kidneypath #renal
𝗧𝗢𝗗𝗔𝗬: ISN-@goKDIGO Webinar: "Women and Kidney Health: Insights from the KDIGO Controversies Conference."
🗣️ Sofia Ahmed, @gb_piccoli
👥 Christina Wyatt
🗓️ May 29
🕑 5:00 pm CEST
🔗 Free registration: http://lite.spr.ly/6005HU3W
KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis. The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) was recently available for public review. The guideline is now being prepared for publication, incorporating feedback received during the public review period.
The KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children was published online in April 2025 and will be available in the May issue of the Supplement of Kidney International, with an Executive Summary in the main pages of the journal. This new guideline represents an update to Chapter 4 of The 2021 Clinical
The 2024 Clinical Practice Guideline for the Management of Lupus Nephritis is a focused update of the lupus nephritis (LN) chapter of The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. The Lupus Nephritis Guideline was published in the January 2024 issue of Supplements to Kidney International, with an Executive Summary published
The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) and Executive Summary are now published online in Supplement to Kidney International and Kidney International, respectively, and available on the KDIGO website. The Guideline was co-chaired by Ian de Boer, MD, MS (United States), and Peter Rossing, MD, DMSc (Denmark), who
